These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6156583

  • 1. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J, Michelot R, Chéramy A.
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract] [Full Text] [Related]

  • 2. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
    Hanson GR, Alphs L, Wolf W, Levine R, Lovenberg W.
    J Pharmacol Exp Ther; 1981 Aug; 218(2):568-74. PubMed ID: 6166743
    [Abstract] [Full Text] [Related]

  • 3. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R, Leviel V, Giorguieff-Chesselet MF, Chéramy A, Glowinski J.
    Life Sci; 1979 Feb 19; 24(8):715-23. PubMed ID: 86931
    [No Abstract] [Full Text] [Related]

  • 4. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U.
    Exp Brain Res; 1986 Feb 19; 64(1):193-207. PubMed ID: 2429859
    [Abstract] [Full Text] [Related]

  • 5. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M, Manzalini M, Fantin M, Bianchi C, Della Corte L, Morari M.
    J Neurochem; 2005 Apr 19; 93(1):195-205. PubMed ID: 15773919
    [Abstract] [Full Text] [Related]

  • 6. A mouse juvenile or adult slice with preserved functional nigro-striatal dopaminergic neurons.
    Ammari R, Lopez C, Fiorentino H, Gonon F, Hammond C.
    Neuroscience; 2009 Mar 03; 159(1):3-6. PubMed ID: 19032976
    [Abstract] [Full Text] [Related]

  • 7. D-Amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway?
    Bunney BS, Aghajanian GK.
    Adv Biochem Psychopharmacol; 1977 Mar 03; 16():577-82. PubMed ID: 883560
    [No Abstract] [Full Text] [Related]

  • 8. Effect of sensory stimuli on the activity of dopaminergic neurons: involvement of non-dopaminergic nigral neurons and striato-nigral pathways.
    Hommer DW, Bunney BS.
    Life Sci; 1980 Aug 04; 27(5):377-86. PubMed ID: 7412480
    [No Abstract] [Full Text] [Related]

  • 9. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
    Deng YP, Lei WL, Reiner A.
    J Chem Neuroanat; 2006 Dec 04; 32(2-4):101-16. PubMed ID: 16914290
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K, Costa E, Toffano G, Hong JS, Guidotti A.
    J Pharmacol Exp Ther; 1978 Jul 04; 206(1):29-37. PubMed ID: 26799
    [No Abstract] [Full Text] [Related]

  • 11. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
    Di Loreto S, Florio T, Capozzo A, Napolitano A, Adorno D, Scarnati E.
    Exp Neurol; 1996 Apr 04; 138(2):318-26. PubMed ID: 8620930
    [Abstract] [Full Text] [Related]

  • 12. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis.
    Costantini LC, Vozza BM, Snyder-Keller AM.
    Exp Neurol; 1994 Jun 04; 127(2):219-31. PubMed ID: 7913445
    [Abstract] [Full Text] [Related]

  • 13. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C, Cohen G, Dembiec-Cohen D, Van Woert M, Hwang E.
    J Neural Transm Suppl; 1983 Jun 04; 19():37-51. PubMed ID: 6321649
    [Abstract] [Full Text] [Related]

  • 14. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons.
    Cheramy A, Michelot R, Leviel V, Nieoullon A, Glowinski J, Kerdelhue B.
    Brain Res; 1978 Oct 27; 155(2):404-8. PubMed ID: 688024
    [No Abstract] [Full Text] [Related]

  • 15. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.
    Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 23; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 18. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 23; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 19. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor.
    Hansson E, Rönnbäck L.
    Glia; 1988 Feb 23; 1(6):393-7. PubMed ID: 2906631
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptides in striato-nigral pathways.
    Cuello AC, Del Fiacco M, Paxinos G, Somogyi P, Priestley JV.
    J Neural Transm; 1981 Feb 23; 51(1-2):83-96. PubMed ID: 6167672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.